Differential Gene Expression Analysis of Human Ovarian Follicular Cumulus and Mural Granulosa Cells Under the Influence of Insulin in IVF Ovulatory Women and Polycystic Ovary Syndrome Patients Through Network Analysis

References

• Che Y, Yu J, Li YS, Zhu YC, Tao T. Polycystic ovary syndrome: challenges and possible solutions. J Clin Med. 2023;12(4):1500. Published February 14, 2023. doi:10.3390/jcm12041500.
   PubMed Web of Science ®Google Scholar
• Tan M, Cheng Y, Zhong X, et al. LNK promotes granulosa cell apoptosis in PCOS via negatively regulating insulin-stimulated AKT-FOXO3 pathway. Aging (Albany NY). 2021;13(3):4617–4633. doi:10.18632/aging.202421.
   PubMedGoogle Scholar
• Fathiya AH, Al Azawi E, Chitme HR. Common risk factors among females seeking treatment for infertility in Muscat. World J Pharm Res. 2014 July 20;3(7):79–92.
   Google Scholar
• Akintayo CO, Johnson AD, Badejogbin OC, et al. High fructose-enriched diet synergistically exacerbates endocrine but not metabolic changes in letrozole-induced polycystic ovarian syndrome in Wistar rats. Heliyon. 2021;7(1):e05890. Published January 50, 2021. doi:10.1016/j.heliyon.2020.e05890.
   PubMed Web of Science ®Google Scholar
• Johnson JE, Daley D, Tarta C, Stanciu PI. Risk of endometrial cancer in patients with polycystic ovarian syndrome: a meta‑analysis. Oncol Lett. 2023;25(4):168. Published March 8, 2023. doi:10.3892/ol.2023.13754.
   PubMed Web of Science ®Google Scholar
• Chitme HR, Al Azawi EAK, Al Abri AM, et al. Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome. J Taibah Univ Med Sci. 2017;12(2):139–145. Published January 13, 2017. doi:10.1016/j.jtumed.2016.11.005.
   PubMed Web of Science ®Google Scholar
• Dadachanji R, Patil A, Joshi B, Mukherjee S, Qu F. Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women. PLoS One. 2021;16(2):e0246862. Published February 26, 2021. doi:10.1371/journal.pone.0246862.
   PubMed Web of Science ®Google Scholar
• Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health. 2018;15(11):2589. Published November 20, 2018. doi:10.3390/ijerph15112589.
   PubMed Web of Science ®Google Scholar
• Chitme HR, Al Azawi E, Al Abri AM, et al. Insulin sensitivity and resistance in infertile women with polycystic ovary syndrome. J Gynecol And Womens Health. 2017;6(5). doi:10.19080/jgwh.2017.06.555700.
   Google Scholar
• Macut D, Bjekić-Macut J, Rahelić D, Doknić M. Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pract. 2017;130:163–170. doi:10.1016/j.diabres.2017.06.011.
   PubMed Web of Science ®Google Scholar
• Bal TT, Akaras N, Demir Ö, Ugan RA. Protective effect of astaxanthin and metformin in the liver of rats in which the polycystic ovary syndrome model was formed by giving letrozole. Iran J Basic Med Sci. 2023;26(6):688–694. doi:10.22038/IJBMS.2023.68032.14872.
   PubMed Web of Science ®Google Scholar
• Rani R, Chitme HR, Kukreti N, et al. Regulation of insulin resistance, lipid profile and glucose metabolism associated with polycystic ovary syndrome by Tinospora cordifolia. Nutrients. 2023;15(10):2238. Published May 9, 2023. doi:10.3390/nu15102238.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16(1):9. Published January 11, 2023. doi:10.1186/s13048-022-01091-0.
   PubMed Web of Science ®Google Scholar
• Chitme HR, Al Azawi E, Al Manwari HA, Al Saadi AA, Al Dulaimi MA. Role of cystic fluid growth factors and inflammatory mediators in pathogenesis of polycystic ovary syndrome. J Gynaecol & Repro Medi. 2019;3:1–7.
   Google Scholar
• Vilariño-García T, Guadix P, Dorado-Silva M, Sánchez-Martín P, Pérez-Pérez A, Sánchez-Margalet V. Decreased expression of Sam68 is associated with insulin resistance in granulosa cells from PCOS patients. Cells. 2022;11(18):2821. Published September 9, 2022. doi:10.3390/cells11182821.
   PubMed Web of Science ®Google Scholar
• Sharma P, Jain M, Halder A. An investigation of steroid biosynthesis pathway genes in women with polycystic ovary syndrome. J Hum Reprod Sci. 2022;15(3):240–249. doi:10.4103/jhrs.jhrs_86_22.
   PubMedGoogle Scholar
• Dompe C, Kulus M, Stefańska K, et al. Human granulosa cells-stemness properties, molecular cross-talk and Follicular Angiogenesis. Cells. 2021;10(6):1396. Published June 5, 2021. doi:10.3390/cells10061396.
   PubMed Web of Science ®Google Scholar
• Richani D, Gilchrist RB. The epidermal growth factor network: role in oocyte growth, maturation and developmental competence. Hum Reprod Update. 2018;24(1):1–14. doi:10.1093/humupd/dmx029.
   PubMed Web of Science ®Google Scholar
• Turathum B, Gao EM, Chian RC. The function of cumulus cells in oocyte growth and maturation and in subsequent ovulation and fertilization. Cells. 2021;10(9):2292. Published September 2, 2021. doi:10.3390/cells10092292.
   PubMed Web of Science ®Google Scholar
• Miętkiewska K, Kordowitzki P, Pareek CS. Effects of heat stress on bovine oocytes and early embryonic development-an update. Cells. 2022;11(24):4073. Published December 16, 2022. doi:10.3390/cells11244073.
   PubMed Web of Science ®Google Scholar
• He M, Zhang T, Yang Y, Wang C. Mechanisms of oocyte maturation and related epigenetic regulation. Front Cell Dev Biol. 2021;9:654028. Published March 19, 2021. doi:10.3389/fcell.2021.654028.
   PubMed Web of Science ®Google Scholar
• Islam MS, Afrin S, Jones SI, Segars J. Selective progesterone receptor modulators-mechanisms and therapeutic utility. Endocr Rev. 2020;41(5):bnaa012. doi:10.1210/endrev/bnaa012.
   PubMed Web of Science ®Google Scholar
• Zhao S, Xu H, Cui Y, et al. Metabolic actions of insulin in ovarian granulosa cells were unaffected by hyperandrogenism. Endocrine. 2016;53(3):823–830. doi:10.1007/s12020-016-0949-y.
   PubMed Web of Science ®Google Scholar
• Jiang JY, Xiong H, Cao M, Xia X, Sirard MA, Tsang BK. Mural granulosa cell gene expression associated with oocyte developmental competence. J Ovarian Res. 2010;3:6. Published March 6, 2010. doi:10.1186/1757-2215-3-6.
   PubMed Web of Science ®Google Scholar
• Khaghani AJ, Farrokh P, Zavareh S. Epigenetic effects of bisphenol a on granulosa cells of mouse follicles during in vitro culture: an experimental study. Int J Reprod Biomed. 2021;19(2):129–136. Published February 21, 2021. doi:10.18502/ijrm.v19i2.8471.
   PubMed Web of Science ®Google Scholar
• Bachelot A. Polycystic ovarian syndrome: clinical and biological diagnosis. Le syndrome des ovaires polykystiques : diagnostic clinique et biologique. Ann Biol Clin (Paris). 2016;74(6):661–667. doi:10.1684/abc.2016.1184.
   PubMed Web of Science ®Google Scholar
• Pant P, Chitme H, Sircar R, Prasad R, Prasad HO. Genome-wide association study for single nucleotide polymorphism associated with mural and cumulus granulosa cells of PCOS (polycystic ovary syndrome) and non-PCOS patients. Future J Pharma Sci. 2023;9(1). doi:10.1186/s43094-023-00475-3.
   Web of Science ®Google Scholar
• Gao EM, Turathum B, Wang L, et al. The differential metabolomes in cumulus and mural granulosa cells from human preovulatory follicles. Reprod Sci. 2022;29(4):1343–1356. doi:10.1007/s43032-021-00691-3.
   PubMed Web of Science ®Google Scholar
• Rice S, Christoforidis N, Gadd C, et al. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod. 2005;20(2):373–381. doi:10.1093/humrep/deh609.
   PubMed Web of Science ®Google Scholar
• Beschta S, Eubler K, Bohne N, et al. A rapid and robust method for the cryopreservation of human granulosa cells. Histochem Cell Biol. 2021;156(5):509–517. doi:10.1007/s00418-021-02019-3.
   PubMed Web of Science ®Google Scholar
• Özçaka Ö, Buduneli N, Ceyhan BO, et al. Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation? J Periodontol. 2013;84(12):1827–1837. doi:10.1902/jop.2013.120483.
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Louwers YV, Taylor KD, et al. Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome. Fertil Steril. 2011;95(5):1736–41.e411. doi:10.1016/j.fertnstert.2011.01.015.
   PubMed Web of Science ®Google Scholar
• Kumar A, Barki S, Raghav V, Chaturvedi A, Kumar KVSH. Correlation of vitamin D with metabolic parameters in polycystic ovarian syndrome. J Family Med Prim Care. 2017;6(1):115–119. doi:10.4103/2249-4863.214985.
   PubMedGoogle Scholar
• Unluhizarci K, Karaca Z, Kelestimur F. Role of insulin and insulin resistance in androgen excess disorders. World J Diabetes. 2021;12(5):616–629. doi:10.4239/wjd.v12.i5.616.
   PubMed Web of Science ®Google Scholar
• McCartney CR, Campbell RE. Abnormal GnRH pulsatility in polycystic ovary syndrome: recent insights. Curr Opin Endocr Metab Res. 2020;12:78–84. doi:10.1016/j.coemr.2020.04.005.
   PubMedGoogle Scholar
• J T, N MM. Are beta 2-adrenergic receptor gene single-nucleotide polymorphisms associated with polycystic ovary syndrome? a pharmacogenetic study. Gynecol & Obs. 2015;5(12). doi:10.4172/2161-0932.1000343.
   Google Scholar
• Pant P, Chitme H. Inflammation and ovulation. IntechOpen EBooks. 2020 October 05. Published. doi:10.5772/intechopen.94107.
   Google Scholar
• Zhuang Z, Pan X, Zhao K, et al. The effect of interleukin-6 (IL-6), interleukin-11 (IL-11), signal transducer and activator of transcription 3 (STAT3), and AKT signaling on adipocyte proliferation in a rat model of polycystic ovary syndrome. Med Sci Monit. 2019;25:7218–7227.Published September 26, 2019. 10.12659/MSM.916385
   PubMed Web of Science ®Google Scholar
• Staszkiewicz J, Skowronski MT, Kaminski T, et al. Expression of proopiomelanocortin, proenkephalin and prodynorphin genes in porcine theca and granulosa cells. Anim Reprod Sci. 2007;101(1–2):97–112. doi:10.1016/j.anireprosci.2006.09.003.
   PubMed Web of Science ®Google Scholar
• McIlvenna LC, Patten RK, McAinch AJ, Rodgers RJ, Stepto NK, Moreno-Asso A. Transforming growth factor beta 1 alters glucose uptake but not insulin signalling in human primary myotubes from women with and without polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:732338. Published October 11, 2021. doi:10.3389/fendo.2021.732338.
   PubMed Web of Science ®Google Scholar
• Gong Y, Luo S, Fan P, Zhu H, Li Y, Huang W. Growth hormone activates PI3K/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2020;18(1):121. Published December 7, 2020. doi:10.1186/s12958-020-00677-x.
   PubMed Web of Science ®Google Scholar
• Tripathi S, Flobak Å, Chawla K, et al. The gastrin and cholecystokinin receptors mediated signaling network: a scaffold for data analysis and new hypotheses on regulatory mechanisms. BMC Syst Biol. 2015;9(1):40. Published July 24, 2015. doi:10.1186/s12918-015-0181-z.
   PubMedGoogle Scholar
• Bishop CV, Takahashi DL, Luo F, et al. The combined impact of testosterone and Western-style diet on endometriosis severity and progression in rhesus macaques† [published correction appears in Biol Reprod. 2023 May 22]. Biol Reprod. 2023;108(1):72–80. doi:10.1093/biolre/ioac183.
   PubMedGoogle Scholar
• Zangeneh FZ, Naghizadeh MM, Bagheri M, Jafarabadi M. Are CRH & NGF as psychoneuroimmune regulators in women with polycystic ovary syndrome? Gynecol Endocrinol. 2017;33(3):227–233. doi:10.1080/09513590.2016.1250152.
   PubMed Web of Science ®Google Scholar
• Szymanska M, Shrestha K, Girsh E, et al. Reduced endothelin-2 and hypoxic signaling pathways in Granulosa-Lutein cells of PCOS women. Int J Mol Sci. 2021;22(15):8216. Published July 30, 2021. doi:10.3390/ijms22158216.
   PubMed Web of Science ®Google Scholar
• Szeliga A, Rudnicka E, Maciejewska-Jeske M, et al. Neuroendocrine determinants of polycystic ovary syndrome. Int J Environ Res Public Health. 2022;19(5):3089. Published March 6, 2022. doi:10.3390/ijerph19053089.
   PubMed Web of Science ®Google Scholar
• Cheng F, NYH N, Tam CHT, et al. Association between FGF19, FGF21 and lipocalin-2, and diabetes progression in PCOS. Endocr Connect. 2021;10(10):1243–1252. Published September 28, 2021. doi:10.1530/EC-21-0082.
   PubMed Web of Science ®Google Scholar
• Li J, Chen H, Gou M, et al. Molecular features of polycystic ovary syndrome revealed by transcriptome analysis of oocytes and cumulus cells. Front Cell Dev Biol. 2021;9:735684. Published September 6, 2021. doi:10.3389/fcell.2021.735684.
   PubMed Web of Science ®Google Scholar
• Kulkarni R, Teves ME, Han AX, McAllister JM, Strauss JF. 3rd colocalization of polycystic ovary syndrome candidate gene products in theca cells suggests novel signaling pathways. J Endocr Soc. 2019;3(12):2204–2223. Published September 16, 2019. doi:10.1210/js.2019-00169.
   PubMed Web of Science ®Google Scholar
• Aydos A, Gurel A, Oztemur Islakoglu Y, Wolfe A, et al. Identification of polycystic ovary syndrome (PCOS) specific genes in cumulus and mural granulosa cells. PLoS One. 2016;11(12):e0168875. Published December 20, 2016. doi:10.1371/journal.pone.0168875.
   PubMed Web of Science ®Google Scholar
• Dennett CC, Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes Spectr. 2015;28(2):116–120. doi:10.2337/diaspect.28.2.116.
   PubMedGoogle Scholar
• Liu R, Bai S, Zheng S, et al. Identification of the metabolomics signature of human follicular fluid from PCOS women with insulin resistance. Dis Markers. 2022;2022:1–10. Published March 20, 2022. doi:10.1155/2022/6877541.
   Web of Science ®Google Scholar
• Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36. doi:10.1016/j.jsbmb.2018.04.008.
   PubMed Web of Science ®Google Scholar
• Scarfò G, Daniele S, Fusi J, et al. Metabolic and molecular mechanisms of diet and physical exercise in the management of polycystic ovarian syndrome. Biomedicines. 2022;10(6):1305. Published June 2, 2022. doi:10.3390/biomedicines10061305.
   PubMed Web of Science ®Google Scholar
• Kanaka V, Proikakis S, Drakakis P, Loutradis D, Tsangaris GT. Implementing a preimplantation proteomic approach to advance assisted reproduction technologies in the framework of predictive, preventive, and personalized medicine. Epma J. 2022;13(2):237–260. Published May 21, 2022. doi:10.1007/s13167-022-00282-5.
   PubMed Web of Science ®Google Scholar
• Li Q, Lan P. Activation of immune signals during organ transplantation. Signal Transduct Target Ther. 2023;8(1):110. Published March 11, 2023. doi:10.1038/s41392-023-01377-9.
   PubMed Web of Science ®Google Scholar
• Grzybowska EA. Calcium-binding proteins with disordered structure and their role in secretion, storage, and cellular signaling. Biomolecules. 2018;8(2):42. Published June 19. doi:10.3390/biom8020042.
   PubMed Web of Science ®Google Scholar
• Kiapekou E, Zapanti E, Voukelatou D, et al. Corticotropin-releasing hormone inhibits in vitro oocyte maturation in mice. Fertil Steril. 2011;95(4):1497–9.e1. doi:10.1016/j.fertnstert.2010.12.023.
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu X, Li F, et al. Overexpression of hypoxia-inducible factor 1α and excessive vascularization in the peri-implantation endometrium of infertile women with chronic endometritis. Front Endocrinol (Lausanne). 2022;13:1001437. Published December 1, 2022. doi:10.3389/fendo.2022.1001437.
   PubMed Web of Science ®Google Scholar
• Zou J, Li Y, Liao N, et al. Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis. J Ovarian Res. 2022;15(1):30. Published February 28, 2022. doi:10.1186/s13048-022-00962-w.
   PubMed Web of Science ®Google Scholar
• Sayutti N, Abu MA, Ahmad MF. PCOS and role of cumulus gene expression in assessing oocytes quality. Front Endocrinol (Lausanne). 2022;13:843867. Published May 26, 2022. doi:10.3389/fendo.2022.843867.
   PubMed Web of Science ®Google Scholar
• Yilmaz B, Vellanki P, Ata B, Yildiz BO. Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2018;109(2):356–364.e32. doi:10.1016/j.fertnstert.2017.10.018.
   PubMed Web of Science ®Google Scholar
• Sangaraju SL, Yepez D, Grandes XA, Talanki Manjunatha R, Habib S. Cardio-metabolic disease and polycystic ovarian syndrome (PCOS): a narrative review. Cureus. 2022;14(5):e25076. Published May 17, 2022. doi:10.7759/cureus.25076.
   PubMed Web of Science ®Google Scholar
• Liauchonak I, Dawoud F, Riat Y, et al. The biased g-protein-coupled receptor agonism bridges the gap between the insulin receptor and the metabolic syndrome. Int J Mol Sci. 2018;19(2):575. Published February 17, 2018. doi:10.3390/ijms19020575.
   PubMed Web of Science ®Google Scholar
• Zhao D, Qu Q, Dai H, et al. Effects of hypoxia‑inducible factor‑1α on endometrial receptivity of women with polycystic ovary syndrome. Mol Med Rep. 2018;17(1):414–421. doi:10.3892/mmr.2017.7890.
   PubMed Web of Science ®Google Scholar
• Muzammal M, Ahmad S, Ali MZ, Khan MA. Alopecia-mental retardation syndrome: molecular genetics of a rare neuro-dermal disorder. Ann Hum Genet. 2021;85(5):147–154. doi:10.1111/ahg.12425.
   PubMed Web of Science ®Google Scholar
• Reza Sailani M, Jahanbani F, Nasiri J, et al. Association of AHSG with alopecia and mental retardation (APMR) syndrome. Hum Genet. 2017;136(3):287–296. doi:10.1007/s00439-016-1756-5.
   PubMed Web of Science ®Google Scholar
• Yao CH, Park JS, Kurmi K, et al. Uncoupled glycerol-3-phosphate shuttle in kidney cancer reveals that cytosolic GPD is essential to support lipid synthesis. Mol Cell. 2023;83(8):1340–1349.e7. doi:10.1016/j.molcel.2023.03.023.
   PubMed Web of Science ®Google Scholar
• Hemshekhar M, Anaparti V, Mookherjee N. Functions of cationic host defense peptides in immunity. Pharma (Basel). 2016;9(3):40. Published July 4, 2016. doi:10.3390/ph9030040.
   Google Scholar
• Hemshekhar M, Choi KG, Mookherjee N. Host defense peptide LL-37-Mediated chemoattractant properties, but not anti-inflammatory cytokine IL-1RA production, is selectively controlled by cdc42 rho GTPase via g protein-coupled receptors and jnk mitogen-activated Protein kinase. Front Immunol. 2018;9:1871. Published August 13, 2018. doi:10.3389/fimmu.2018.01871.
   PubMed Web of Science ®Google Scholar
• Chen MX, Oh YS, Kim Y. S100A10 and its binding partners in depression and antidepressant actions. Front Mol Neurosci. 2022;15:953066. Published August 15, 2022. doi:10.3389/fnmol.2022.953066.
   PubMed Web of Science ®Google Scholar
• Bedi U, Scheel AH, Hennion M, Begus-Nahrmann Y, Rüschoff J, Johnsen SA. SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms. Oncogene. 2015;34(4):465–473. doi:10.1038/onc.2013.558.
   PubMed Web of Science ®Google Scholar
• Butler AE, Moin ASM, Sathyapalan T, Atkin SL. Components of the complement cascade differ in polycystic ovary syndrome. Int J Mol Sci. 2022;23(20):12232. Published October 13, 2022. doi:10.3390/ijms232012232.
   PubMed Web of Science ®Google Scholar
• Stokkeland LMT, Giskeødegård GF, Ryssdal M, et al. Changes in serum cytokines throughout pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2022;107(1):39–52. doi:10.1210/clinem/dgab684.
   PubMed Web of Science ®Google Scholar
• Khichar A, Gupta S, Mishra S, Meena M. Assessment of inflammatory markers in women with PCOS and their correlation with insulin resistance. Clin Lab. 2021;67(11). doi:10.7754/Clin.Lab.2021.210310.
   PubMed Web of Science ®Google Scholar
• Snyder ML, Shields KJ, Korytkowski MT, Sutton-Tyrrell K, Talbott EO. Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls. Gynecol Endocrinol. 2014;30(7):511–515. doi:10.3109/09513590.2014.895985.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding N, Xin W, Yang X, Wang F. Quantitative proteomics reveals that a prognostic signature of the endometrium of the polycystic ovary syndrome women based on ferroptosis proteins. Front Endocrinol (Lausanne). 2022;13:871945. Published July 14, 2022. doi:10.3389/fendo.2022.871945.
   PubMed Web of Science ®Google Scholar
• Zhang J, Pan M, Zhang Q, Wang F, Fan QW. Association of tumor markers with total testosterone in the serum of women with polycystic ovary syndrome. Clin Exp Obstet Gynecol. 2022;49(7):162. doi:10.31083/j.ceog4907162.
   Web of Science ®Google Scholar
• Campi I, Vannucchi G, Muller I, et al. Therapy with different dose regimens of rituximab in patients with active moderate-to-severe graves’ orbitopathy. Front Endocrinol. 2022;12:12. doi:10.3389/fendo.2021.790246
   Web of Science ®Google Scholar